Review



alomone tamapin  (Alomone Labs)


Bioz Verified Symbol Alomone Labs is a verified supplier
Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Alomone Labs alomone tamapin
    a-b Representative ventral root recordings showing the effect of the broad-spectrum SK <t>activator</t> <t>1-EBIO</t> ( a ; 5 mM) and the SK2/3-selective activator CyPPA ( b ; 0.3-0.4 mM) on ongoing fictive locomotion induced by NMDA/5-HT (5/10 µM). Top left in a and b : Schematic of the isolated spinal cord preparation illustrating focal drug puff application onto rhythmogenic segments (L 1 -L 2 ) and bilateral L5 ventral root recordings (L5R, L5L). Bottom: Raw ventral root activity (black) superimposed with low-pass filtered envelopes (blue for 1-EBIO, orange for CyPPA); vertical arrows indicate puff onset. Top right: Expanded time windows ( a’ , b’ ) of the recordings shown below, highlighting rhythm suppression. c-d Representative recordings showing the induction of locomotor-like activity in quiescent preparations (subliminal NMDA/5-HT: 0-1/10 µM) by the SK2/3 inhibitor <t>tamapin</t> ( c ; 1 µM) or the T-type calcium channel blocker nickel ( d ; 10-20 µM). The experimental layout and display are identical to a, b . Low-pass filtered envelopes are shown in purple (tamapin) and teal (nickel). Arrows indicate puff onset.
    Alomone Tamapin, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e-150/bio_rxiv__64898__2026__03__19__712770-257-0-0?v=Alomone+Labs
    Average 94 stars, based on 4 article reviews
    alomone tamapin - by Bioz Stars, 2026-07
    94/100 stars

    Images

    1) Product Images from "SK2/3 CHANNELS COUPLE WITH T-TYPE CA 2+ CHANNELS TO GATE SPINAL LOCOMOTOR RHYTHM GENERATION"

    Article Title: SK2/3 CHANNELS COUPLE WITH T-TYPE CA 2+ CHANNELS TO GATE SPINAL LOCOMOTOR RHYTHM GENERATION

    Journal: bioRxiv

    doi: 10.64898/2026.03.19.712770

    a-b Representative ventral root recordings showing the effect of the broad-spectrum SK activator 1-EBIO ( a ; 5 mM) and the SK2/3-selective activator CyPPA ( b ; 0.3-0.4 mM) on ongoing fictive locomotion induced by NMDA/5-HT (5/10 µM). Top left in a and b : Schematic of the isolated spinal cord preparation illustrating focal drug puff application onto rhythmogenic segments (L 1 -L 2 ) and bilateral L5 ventral root recordings (L5R, L5L). Bottom: Raw ventral root activity (black) superimposed with low-pass filtered envelopes (blue for 1-EBIO, orange for CyPPA); vertical arrows indicate puff onset. Top right: Expanded time windows ( a’ , b’ ) of the recordings shown below, highlighting rhythm suppression. c-d Representative recordings showing the induction of locomotor-like activity in quiescent preparations (subliminal NMDA/5-HT: 0-1/10 µM) by the SK2/3 inhibitor tamapin ( c ; 1 µM) or the T-type calcium channel blocker nickel ( d ; 10-20 µM). The experimental layout and display are identical to a, b . Low-pass filtered envelopes are shown in purple (tamapin) and teal (nickel). Arrows indicate puff onset.
    Figure Legend Snippet: a-b Representative ventral root recordings showing the effect of the broad-spectrum SK activator 1-EBIO ( a ; 5 mM) and the SK2/3-selective activator CyPPA ( b ; 0.3-0.4 mM) on ongoing fictive locomotion induced by NMDA/5-HT (5/10 µM). Top left in a and b : Schematic of the isolated spinal cord preparation illustrating focal drug puff application onto rhythmogenic segments (L 1 -L 2 ) and bilateral L5 ventral root recordings (L5R, L5L). Bottom: Raw ventral root activity (black) superimposed with low-pass filtered envelopes (blue for 1-EBIO, orange for CyPPA); vertical arrows indicate puff onset. Top right: Expanded time windows ( a’ , b’ ) of the recordings shown below, highlighting rhythm suppression. c-d Representative recordings showing the induction of locomotor-like activity in quiescent preparations (subliminal NMDA/5-HT: 0-1/10 µM) by the SK2/3 inhibitor tamapin ( c ; 1 µM) or the T-type calcium channel blocker nickel ( d ; 10-20 µM). The experimental layout and display are identical to a, b . Low-pass filtered envelopes are shown in purple (tamapin) and teal (nickel). Arrows indicate puff onset.

    Techniques Used: Isolation, Activity Assay



    Similar Products

    h460 h3122 kyse 150 m21 mda mb 231 mda mb 435s raw 264 7 e coli atcc 25922  (ATCC)
    96
    ATCC h460 h3122 kyse 150 m21 mda mb 231 mda mb 435s raw 264 7 e coli atcc 25922
    H460 H3122 Kyse 150 M21 Mda Mb 231 Mda Mb 435s Raw 264 7 E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e-150/pm41892485-72-367-377?v=ATCC
    Average 96 stars, based on 1 article reviews
    h460 h3122 kyse 150 m21 mda mb 231 mda mb 435s raw 264 7 e coli atcc 25922 - by Bioz Stars, 2026-07
    96/100 stars
    		  Buy from Supplier
    sartolab rf  (Sartorius AG)
    94
    Sartorius AG sartolab rf
    Sartolab Rf, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e-150/pm41990504-64-8-15?v=Sartorius+AG
    Average 94 stars, based on 1 article reviews
    sartolab rf - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    model 150 e  (Taber Industries)
    86
    Taber Industries model 150 e
    Model 150 E, supplied by Taber Industries, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e-150/us12623442-183-12-15?v=Taber+Industries
    Average 86 stars, based on 1 article reviews
    model 150 e - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    e series uv 150 photoreactor flow chemistry system  (Vapourtec Ltd)
    86
    Vapourtec Ltd e series uv 150 photoreactor flow chemistry system
    E Series Uv 150 Photoreactor Flow Chemistry System, supplied by Vapourtec Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e-150/pm42106388-181-1-0?v=Vapourtec+Ltd
    Average 86 stars, based on 1 article reviews
    e series uv 150 photoreactor flow chemistry system - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    alomone tamapin  (Alomone Labs)
    94
    Alomone Labs alomone tamapin
    a-b Representative ventral root recordings showing the effect of the broad-spectrum SK <t>activator</t> <t>1-EBIO</t> ( a ; 5 mM) and the SK2/3-selective activator CyPPA ( b ; 0.3-0.4 mM) on ongoing fictive locomotion induced by NMDA/5-HT (5/10 µM). Top left in a and b : Schematic of the isolated spinal cord preparation illustrating focal drug puff application onto rhythmogenic segments (L 1 -L 2 ) and bilateral L5 ventral root recordings (L5R, L5L). Bottom: Raw ventral root activity (black) superimposed with low-pass filtered envelopes (blue for 1-EBIO, orange for CyPPA); vertical arrows indicate puff onset. Top right: Expanded time windows ( a’ , b’ ) of the recordings shown below, highlighting rhythm suppression. c-d Representative recordings showing the induction of locomotor-like activity in quiescent preparations (subliminal NMDA/5-HT: 0-1/10 µM) by the SK2/3 inhibitor <t>tamapin</t> ( c ; 1 µM) or the T-type calcium channel blocker nickel ( d ; 10-20 µM). The experimental layout and display are identical to a, b . Low-pass filtered envelopes are shown in purple (tamapin) and teal (nickel). Arrows indicate puff onset.
    Alomone Tamapin, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e-150/bio_rxiv__64898__2026__03__19__712770-257-0-0?v=Alomone+Labs
    Average 94 stars, based on 1 article reviews
    alomone tamapin - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    alexa fluor 647 ar icl e i n p re ss 715 545 150 jackson immuno research  (Jackson Immuno)
    96
    Jackson Immuno alexa fluor 647 ar icl e i n p re ss 715 545 150 jackson immuno research
    a-b Representative ventral root recordings showing the effect of the broad-spectrum SK <t>activator</t> <t>1-EBIO</t> ( a ; 5 mM) and the SK2/3-selective activator CyPPA ( b ; 0.3-0.4 mM) on ongoing fictive locomotion induced by NMDA/5-HT (5/10 µM). Top left in a and b : Schematic of the isolated spinal cord preparation illustrating focal drug puff application onto rhythmogenic segments (L 1 -L 2 ) and bilateral L5 ventral root recordings (L5R, L5L). Bottom: Raw ventral root activity (black) superimposed with low-pass filtered envelopes (blue for 1-EBIO, orange for CyPPA); vertical arrows indicate puff onset. Top right: Expanded time windows ( a’ , b’ ) of the recordings shown below, highlighting rhythm suppression. c-d Representative recordings showing the induction of locomotor-like activity in quiescent preparations (subliminal NMDA/5-HT: 0-1/10 µM) by the SK2/3 inhibitor <t>tamapin</t> ( c ; 1 µM) or the T-type calcium channel blocker nickel ( d ; 10-20 µM). The experimental layout and display are identical to a, b . Low-pass filtered envelopes are shown in purple (tamapin) and teal (nickel). Arrows indicate puff onset.
    Alexa Fluor 647 Ar Icl E I N P Re Ss 715 545 150 Jackson Immuno Research, supplied by Jackson Immuno, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e-150/pm41691309-427-189-201?v=Jackson+Immuno
    Average 96 stars, based on 1 article reviews
    alexa fluor 647 ar icl e i n p re ss 715 545 150 jackson immuno research - by Bioz Stars, 2026-07
    96/100 stars
    		  Buy from Supplier
    growth conditions 150 s cerevisiae atcc 13007  (ATCC)
    98
    ATCC growth conditions 150 s cerevisiae atcc 13007
    a-b Representative ventral root recordings showing the effect of the broad-spectrum SK <t>activator</t> <t>1-EBIO</t> ( a ; 5 mM) and the SK2/3-selective activator CyPPA ( b ; 0.3-0.4 mM) on ongoing fictive locomotion induced by NMDA/5-HT (5/10 µM). Top left in a and b : Schematic of the isolated spinal cord preparation illustrating focal drug puff application onto rhythmogenic segments (L 1 -L 2 ) and bilateral L5 ventral root recordings (L5R, L5L). Bottom: Raw ventral root activity (black) superimposed with low-pass filtered envelopes (blue for 1-EBIO, orange for CyPPA); vertical arrows indicate puff onset. Top right: Expanded time windows ( a’ , b’ ) of the recordings shown below, highlighting rhythm suppression. c-d Representative recordings showing the induction of locomotor-like activity in quiescent preparations (subliminal NMDA/5-HT: 0-1/10 µM) by the SK2/3 inhibitor <t>tamapin</t> ( c ; 1 µM) or the T-type calcium channel blocker nickel ( d ; 10-20 µM). The experimental layout and display are identical to a, b . Low-pass filtered envelopes are shown in purple (tamapin) and teal (nickel). Arrows indicate puff onset.
    Growth Conditions 150 S Cerevisiae Atcc 13007, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e-150/pm41609413-70-2-7?v=ATCC
    Average 98 stars, based on 1 article reviews
    growth conditions 150 s cerevisiae atcc 13007 - by Bioz Stars, 2026-07
    98/100 stars
    		  Buy from Supplier
    sterile filter  (Sartorius AG)
    94
    Sartorius AG sterile filter
    a-b Representative ventral root recordings showing the effect of the broad-spectrum SK <t>activator</t> <t>1-EBIO</t> ( a ; 5 mM) and the SK2/3-selective activator CyPPA ( b ; 0.3-0.4 mM) on ongoing fictive locomotion induced by NMDA/5-HT (5/10 µM). Top left in a and b : Schematic of the isolated spinal cord preparation illustrating focal drug puff application onto rhythmogenic segments (L 1 -L 2 ) and bilateral L5 ventral root recordings (L5R, L5L). Bottom: Raw ventral root activity (black) superimposed with low-pass filtered envelopes (blue for 1-EBIO, orange for CyPPA); vertical arrows indicate puff onset. Top right: Expanded time windows ( a’ , b’ ) of the recordings shown below, highlighting rhythm suppression. c-d Representative recordings showing the induction of locomotor-like activity in quiescent preparations (subliminal NMDA/5-HT: 0-1/10 µM) by the SK2/3 inhibitor <t>tamapin</t> ( c ; 1 µM) or the T-type calcium channel blocker nickel ( d ; 10-20 µM). The experimental layout and display are identical to a, b . Low-pass filtered envelopes are shown in purple (tamapin) and teal (nickel). Arrows indicate puff onset.
    Sterile Filter, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e-150/pm41521291-96-25-30?v=Sartorius+AG
    Average 94 stars, based on 1 article reviews
    sterile filter - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    filter  (Sartorius AG)
    94
    Sartorius AG filter
    a-b Representative ventral root recordings showing the effect of the broad-spectrum SK <t>activator</t> <t>1-EBIO</t> ( a ; 5 mM) and the SK2/3-selective activator CyPPA ( b ; 0.3-0.4 mM) on ongoing fictive locomotion induced by NMDA/5-HT (5/10 µM). Top left in a and b : Schematic of the isolated spinal cord preparation illustrating focal drug puff application onto rhythmogenic segments (L 1 -L 2 ) and bilateral L5 ventral root recordings (L5R, L5L). Bottom: Raw ventral root activity (black) superimposed with low-pass filtered envelopes (blue for 1-EBIO, orange for CyPPA); vertical arrows indicate puff onset. Top right: Expanded time windows ( a’ , b’ ) of the recordings shown below, highlighting rhythm suppression. c-d Representative recordings showing the induction of locomotor-like activity in quiescent preparations (subliminal NMDA/5-HT: 0-1/10 µM) by the SK2/3 inhibitor <t>tamapin</t> ( c ; 1 µM) or the T-type calcium channel blocker nickel ( d ; 10-20 µM). The experimental layout and display are identical to a, b . Low-pass filtered envelopes are shown in purple (tamapin) and teal (nickel). Arrows indicate puff onset.
    Filter, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e-150/pmc12779989-224-15-16?v=Sartorius+AG
    Average 94 stars, based on 1 article reviews
    filter - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    e coli atcc 35 150  (ATCC)
    97
    ATCC e coli atcc 35 150
    a-b Representative ventral root recordings showing the effect of the broad-spectrum SK <t>activator</t> <t>1-EBIO</t> ( a ; 5 mM) and the SK2/3-selective activator CyPPA ( b ; 0.3-0.4 mM) on ongoing fictive locomotion induced by NMDA/5-HT (5/10 µM). Top left in a and b : Schematic of the isolated spinal cord preparation illustrating focal drug puff application onto rhythmogenic segments (L 1 -L 2 ) and bilateral L5 ventral root recordings (L5R, L5L). Bottom: Raw ventral root activity (black) superimposed with low-pass filtered envelopes (blue for 1-EBIO, orange for CyPPA); vertical arrows indicate puff onset. Top right: Expanded time windows ( a’ , b’ ) of the recordings shown below, highlighting rhythm suppression. c-d Representative recordings showing the induction of locomotor-like activity in quiescent preparations (subliminal NMDA/5-HT: 0-1/10 µM) by the SK2/3 inhibitor <t>tamapin</t> ( c ; 1 µM) or the T-type calcium channel blocker nickel ( d ; 10-20 µM). The experimental layout and display are identical to a, b . Low-pass filtered envelopes are shown in purple (tamapin) and teal (nickel). Arrows indicate puff onset.
    E Coli Atcc 35 150, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e-150/pm41222843-32-10-12?v=ATCC
    Average 97 stars, based on 1 article reviews
    e coli atcc 35 150 - by Bioz Stars, 2026-07
    97/100 stars
    		  Buy from Supplier

    Image Search Results


    a-b Representative ventral root recordings showing the effect of the broad-spectrum SK activator 1-EBIO ( a ; 5 mM) and the SK2/3-selective activator CyPPA ( b ; 0.3-0.4 mM) on ongoing fictive locomotion induced by NMDA/5-HT (5/10 µM). Top left in a and b : Schematic of the isolated spinal cord preparation illustrating focal drug puff application onto rhythmogenic segments (L 1 -L 2 ) and bilateral L5 ventral root recordings (L5R, L5L). Bottom: Raw ventral root activity (black) superimposed with low-pass filtered envelopes (blue for 1-EBIO, orange for CyPPA); vertical arrows indicate puff onset. Top right: Expanded time windows ( a’ , b’ ) of the recordings shown below, highlighting rhythm suppression. c-d Representative recordings showing the induction of locomotor-like activity in quiescent preparations (subliminal NMDA/5-HT: 0-1/10 µM) by the SK2/3 inhibitor tamapin ( c ; 1 µM) or the T-type calcium channel blocker nickel ( d ; 10-20 µM). The experimental layout and display are identical to a, b . Low-pass filtered envelopes are shown in purple (tamapin) and teal (nickel). Arrows indicate puff onset.

    Journal: bioRxiv

    Article Title: SK2/3 CHANNELS COUPLE WITH T-TYPE CA 2+ CHANNELS TO GATE SPINAL LOCOMOTOR RHYTHM GENERATION

    doi: 10.64898/2026.03.19.712770

    Figure Lengend Snippet: a-b Representative ventral root recordings showing the effect of the broad-spectrum SK activator 1-EBIO ( a ; 5 mM) and the SK2/3-selective activator CyPPA ( b ; 0.3-0.4 mM) on ongoing fictive locomotion induced by NMDA/5-HT (5/10 µM). Top left in a and b : Schematic of the isolated spinal cord preparation illustrating focal drug puff application onto rhythmogenic segments (L 1 -L 2 ) and bilateral L5 ventral root recordings (L5R, L5L). Bottom: Raw ventral root activity (black) superimposed with low-pass filtered envelopes (blue for 1-EBIO, orange for CyPPA); vertical arrows indicate puff onset. Top right: Expanded time windows ( a’ , b’ ) of the recordings shown below, highlighting rhythm suppression. c-d Representative recordings showing the induction of locomotor-like activity in quiescent preparations (subliminal NMDA/5-HT: 0-1/10 µM) by the SK2/3 inhibitor tamapin ( c ; 1 µM) or the T-type calcium channel blocker nickel ( d ; 10-20 µM). The experimental layout and display are identical to a, b . Low-pass filtered envelopes are shown in purple (tamapin) and teal (nickel). Arrows indicate puff onset.

    Article Snippet: Alomone: tamapin (5-10 nM), 1-EBIO (200 μM), CyPPA (1-10 μM), and Tram-34 (5 μM).

    Techniques: Isolation, Activity Assay